choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Aprovel

Aprovel Newsletter
  • Handok to exclusively market Abbott’s hyperlipidemia drug in Korea 02 Jan 2025 04:03 GMT

    … fenofibrate), Abbott’s hyperlipidemia treatment, on Wednesday. An agreement … prescribed fibrate-based hyperlipidemia treatment in both global … us to provide comprehensive treatment solutions while strengthening our … marketing Sanofi’s Aprovel and CoAprovel.

  • Generics to replace Aprovel and Prozac in Taiwan 20 Aug 2024 17:54 GMT

    … the Food and Drug Administration (FDA) said on Monday … an antidepressant, after December and November respectively, FDA Deputy … Medical Review and Pharmaceutical Benefits Division. The manufacturer of Aprovel … efficacy of the treatment, its cost-effectiveness …

  • Aprovel 150mg and Prozac no longer available after November 2024 19 Aug 2024 19:19 GMT

    … for only 15.3% of antidepressant prescriptions last year. (Photo: … medications Aprovel 150mg and Prozac will be gradually withdrawn from the pharmaceutical market … from November this year. Food and Drug Administration (FDA) Deputy …

  • Two high blood pressure, depression drugs to be withdrawn from market 19 Aug 2024 14:19 GMT

    … an antihypertensive and an antidepressant, after December and … by local pharmaceutical companies. Generic drugs are those … the Taiwan Generic Pharmaceutical Association. Aprovel 150 mg film … s (NHIA) Medical Review and Pharmaceutical Benefits Division. Tai …

  • Handok hosts symposium, marking launch of hypertension drug Aprovasc 20 Mar 2024 07:22 GMT

    … 301 and 302 clinical trials, which served as the … the Gangnam-gu Internal Medicine Association, presided over the … events, and better treatment adherence compared to single-drug combination therapy. … lecture, Professor Won said Aprovel has a high binding …

  • Sanofi launches combination treatment for hypertension Aprovasc in Korea 02 Feb 2024 05:44 GMT

    … were previously prescribed separate medications. Irbesartan has demonstrated … a phase 3 clinical trial study that demonstrated … treatment and control groups, and no serious adverse drug … following on from our existing Aprovel, Coaprovel, and Rovelito …

  • ‘Adherence is important in treating hypertension, which is why we prescribe combination drugs’ 25 Jan 2024 07:31 GMT

    … combination therapy, pharmaceutical companies are introducing new medications for hypertension. … each additional medication. This means that doctors prescribe medications, but patients … drug that can be used after Aprovel is that it expands the treatment

  • Health Ministry bans sale of eight unauthorised drugs 07 Dec 2023 18:46 GMT

    … Centre for Diabetes – Vaxigrip Tetra, Aprovel 150mg and 300mg, Plavix 75mg … Drugs, the distribution and quality of pharmaceutical products for the prevention and treatment … use these drugs, because illegal drugs are imported without medical supervision,” he …

  • Handok, SK chemicals ride on original ingredients amid combo drug competition 30 Nov 2023 05:47 GMT

    … Sanofi Aventise’s antihypertensive drug Aprovel, with amlodipine, a … two phase 3 clinical trials demonstrated a superior blood … will provide a new treatment option for patients … quot;SK chemicals' pharmaceutical technology and production capabilities have …

  • Health chiefs recall another 25 batches of blood pressure pills over cancer fears 09 Aug 2021 15:04 GMT

    … high blood pressure pills have been … medication. ';Speak with your doctor or pharmacist before stopping any treatment … of affected drugs — several different types of … FT050  Doncaster Pharmaceuticals Group Ltd  Mar 2023  28  Aprovel 75mg Film-Coated …

Satisfied with the content?

Continue to create your account.